These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 26460688

  • 1. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
    Carlos F, Espejel L, Novick D, López R, Flores D.
    Medwave; 2015 Sep 25; 15(8):e6265. PubMed ID: 26460688
    [Abstract] [Full Text] [Related]

  • 2. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
    Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Julious SA, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude E, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Bouhassira D, Bennett DL, Selvarajah D.
    Health Technol Assess; 2022 Oct 25; 26(39):1-100. PubMed ID: 36259684
    [Abstract] [Full Text] [Related]

  • 3. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
    Bellows BK, Nelson RE, Oderda GM, LaFleur J.
    Pain; 2016 Jan 25; 157(1):203-213. PubMed ID: 26397932
    [Abstract] [Full Text] [Related]

  • 4. A cost-utility comparison of four first-line medications in painful diabetic neuropathy.
    O'Connor AB, Noyes K, Holloway RG.
    Pharmacoeconomics; 2008 Jan 25; 26(12):1045-64. PubMed ID: 19014205
    [Abstract] [Full Text] [Related]

  • 5. Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico.
    Carlos F, Ramírez-Gámez J, Dueñas H, Galindo-Suárez RM, Ramos E.
    J Med Econ; 2012 Jan 25; 15(2):233-44. PubMed ID: 22082033
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
    Roy MK, Kuriakose AS, Varma SK, Jacob LA, Beegum NJ.
    Diabetes Metab Syndr; 2017 Jan 25; 11(1):31-35. PubMed ID: 27484440
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amitriptyline, Pregabalin and Duloxetine for Treatment of Painful Diabetic Peripheral Neuropathy.
    Nepal R, Bajracharya MR, Karki BB, Mall D, Shrestha PS, Wasti KP, Bisht A.
    J Nepal Health Res Counc; 2024 Jun 22; 22(1):185-191. PubMed ID: 39080958
    [Abstract] [Full Text] [Related]

  • 10. An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.
    de Salas-Cansado M, Pérez C, Saldaña MT, Navarro A, González-Gómez FJ, Ruiz L, Rejas J.
    Prim Care Diabetes; 2012 Dec 22; 6(4):303-12. PubMed ID: 22595032
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP, Sanchez RJ, Joshi AV, Cappelleri JC, Kulakodlu M, Halpern R.
    Pain Pract; 2012 Mar 22; 12(3):209-18. PubMed ID: 21676163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
    Bouhassira D, Wilhelm S, Schacht A, Perrot S, Kosek E, Cruccu G, Freynhagen R, Tesfaye S, Lledó A, Choy E, Marchettini P, Micó JA, Spaeth M, Skljarevski V, Tölle T.
    Pain; 2014 Oct 22; 155(10):2171-9. PubMed ID: 25168665
    [Abstract] [Full Text] [Related]

  • 16. Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
    Marchettini P, Wilhelm S, Petto H, Tesfaye S, Tölle T, Bouhassira D, Freynhagen R, Cruccu G, Lledó A, Choy E, Kosek E, Micó JA, Späth M, Skljarevski V, Lenox-Smith A, Perrot S.
    Eur J Pain; 2016 Mar 22; 20(3):472-82. PubMed ID: 26311228
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
    Gore M, Zlateva G, Tai KS, Chandran AB, Leslie D.
    Pain Pract; 2011 Mar 22; 11(2):167-79. PubMed ID: 20723096
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.